Filings for Oct 11, 2019 show insider purchases at 18 companies, adding up to roughly $3.5 million. The biggest was NGM (NGM BIOPHARMACEUTICALS INC), where COLUMN GROUP III-A, LP led about $2.2 million of buying.
C-suite buying: five companies. 75 companies had three or more insiders buying in the past 30 days. One buy doesn't make a thesis, but it's a good place to start digging.